| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.077 | 0.07 |